ЛИЧ Кевин (US),РАЙТ Тереса (US),ФЕЛИС Брайан (US),ПФАЙФЕР Ричард (US),КАЛИАС Периклс (US),МАККОЛИ Томас (US)
申请号:
RU2015138443
公开号:
RU2015138443A
申请日:
2014.03.12
申请国别(地区):
RU
年份:
2017
代理人:
摘要:
Methods of treating B2-bradykinin receptor mediated angioedema in a subject by administering a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof. Oral formulations containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the treatment of B2-bradykinin receptor mediated angioedema. Use of a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the manufacture of a medicament for the treatment and/or prevention of a B2-bradykinin receptor mediated angioedema.